Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study.

MLA

Spijkerman, A. M. W., et al. “Prevalence of Macrovascular Disease amongst Type 2 Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: The Hoorn Screening Study.” Journal of Internal Medicine, vol. 256, no. 5, Nov. 2004, pp. 429–36. EBSCOhost, https://doi.org/10.1111/j.1365-2796.2004.01395.x.

APA

Spijkerman, A. M. W., Henry, R. M. A., Dekker, J. M., Nijpels, G., Kostense, P. J., Kors, J. A., Ruwaard, D., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2004). Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. Journal of Internal Medicine, 256(5), 429–436. https://doi.org/10.1111/j.1365-2796.2004.01395.x

Chicago

Spijkerman, A M W, R M A Henry, J M Dekker, G Nijpels, P J Kostense, J A Kors, D Ruwaard, C D A Stehouwer, L M Bouter, and R J Heine. 2004. “Prevalence of Macrovascular Disease amongst Type 2 Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: The Hoorn Screening Study.” Journal of Internal Medicine 256 (5): 429–36. doi:10.1111/j.1365-2796.2004.01395.x.